Ravintsara
Ravintsara, licence 80095327: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- HB Naturals Canada Ltd.
- NPN or DIN-HM
- 80095327
- Status
- Active licence
- Licence date
- 15 November 2019
- Revision date
- Not provided
- Form
- Liquides
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | minimum: 0.15 mL ; maximum: 0.75 mL | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Used in aromatherapy for symptomatic relief of acne/boils. -Used in aromatherapy to relieve minor skin irritation/cuts/bruises/burns. -Used in aromatherapy to help relieve joint/muscle pain associated with sprain/strain/rheumatoid arthritis. -Used in aromatherapy to help relieve colds/cough.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
- Keep out of reach of children. - If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Center. - If symptoms persist or worsen, consult a health care practitioner. - If you have epilepsy or asthma, consult a health care practitioner prior to use. - Avoid exposure of applied area(s) to the sun.
- Contre-indications
- If you are pregnant or breastfeeding, do not use this product.
- Effets indésirables connus
- If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
Source
Official Health Canada record, licence 80095327
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
No ingredient list for this product yet. Have it to hand? Photograph the ingredient list.
Has the product changed? Photograph the packaging.